SANIPEX_LIMITED - Accounts


Company registration number 05994200 (England and Wales)
SANIPEX LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023
PAGES FOR FILING WITH REGISTRAR
SANIPEX LIMITED
COMPANY INFORMATION
Director
A S Cooper
(Appointed 1 November 2022)
Company number
05994200
Registered office
Unit 1
Oakwell Park Trading Estate
Birstall
WF17 9LU
Auditor
Calvert Dawson Ltd
288 Oxford Road
Gomersal
Cleckheaton
West Yorkshire
BD19 4PY
SANIPEX LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
SANIPEX LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2023
31 January 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
660,710
591,346
Current assets
Stocks
3,054,155
1,696,793
Debtors
4
9,364,685
9,250,385
Cash at bank and in hand
92,371
668,787
12,511,211
11,615,965
Creditors: amounts falling due within one year
5
(10,282,503)
(8,594,846)
Net current assets
2,228,708
3,021,119
Net assets
2,889,418
3,612,465
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
2,889,417
3,612,464
Total equity
2,889,418
3,612,465

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 27 April 2023 and are signed on its behalf by:
A S Cooper
Director
Company Registration No. 05994200
SANIPEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023
- 2 -
1
Accounting policies
Company information

Sanipex Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 1, Oakwell Park Trading Estate, Birstall, WF17 9LU.

 

The company is a wholly owned subsidiary of Sanipex S.A., a company registered in the bahamas. Sanipex S.A. prepares consolidated financial statements which include the results of Sanipex Limited.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

These financial statements are prepared on the going concern basis. The director has a reasonable expectation that the company will continue in operational existence for the foreseeable future. However, the director is aware of certain material uncertainties which may cause doubt on the company's ability to continue as a going concern arising from its trading losses and the company's liabilities will continue to be met by the parent company.

The company's operations are funded by the Sanipex Group and the directors of the parent company have confirmed that the group will continue to support the company and advance further additional finance, as required, to fund the operations for a period of at least twelve months from the date of approval of these financial statements.

 

The company reported a loss before tax of £0.7 million in the year to 31 January 2023 (2022: £0.4 million loss). This results in net assets at the balance sheet date of £2.9 million (2022; net assets of £3.6 million). The forecast for the year ended 31 January 2024 indicates that management expect to make a profit of circa £0.2 million in that period.

 

The director has considered the impact of recent global events on the company's trade, workforce and supply chain, as well as the wider economy, and is confident that there are plans in place to deal with any financial losses that may arise.

The director does however recognise that significant uncertainty exists surrounding the the current economic climate and hence there is an inherent risk regarding the success and sustainability of these plans. The risk represents a material uncertainty which may cast significant doubt about the company's ability to continue as a going concern, however the director has concluded that the company remains a going concern whilst such viable options are available to it. The director therefore continues to adapt the going concern basis of preparation for these financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

SANIPEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2023
1
Accounting policies
(Continued)
- 3 -
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and Buildings
Straight line over 20 years
Plant and machinery etc
Between 3 and 5 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

At each reporting date, an assessment is made for impairment. There is an agreement in place that aged stock is bought back by the group at cost, meaning that any provision for slow moving or obsolete stock is not normally required.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

SANIPEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2023
1
Accounting policies
(Continued)
- 4 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.13
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

SANIPEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2023
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
25
26
3
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 February 2022
824,757
211,010
1,035,767
Additions
106,849
28,743
135,592
At 31 January 2023
931,606
239,753
1,171,359
Depreciation and impairment
At 1 February 2022
248,569
195,852
444,421
Depreciation charged in the year
52,051
14,177
66,228
At 31 January 2023
300,620
210,029
510,649
Carrying amount
At 31 January 2023
630,986
29,724
660,710
At 31 January 2022
576,188
15,158
591,346
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
1,347,484
905,051
Amounts owed by group undertakings
7,415,956
7,796,641
Other debtors
601,245
548,693
9,364,685
9,250,385
SANIPEX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2023
- 6 -
5
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
1,037,971
1,832,960
Amounts owed to group undertakings
8,161,986
6,178,928
Taxation and social security
391,034
21,005
Other creditors
691,512
561,953
10,282,503
8,594,846
6
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Senior Statutory Auditor:
Paul Calvert ACA
Statutory Auditor:
Calvert Dawson Ltd
7
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2023
2022
£
£
995,198
1,069,077
2023-01-312022-02-01false27 April 2023CCH SoftwareCCH Accounts Production 2023.100No description of principal activityThis audit opinion is unqualifiedR M NichollsA S Cooper059942002022-02-012023-01-3105994200bus:Director22022-02-012023-01-3105994200bus:Director12022-02-012023-01-3105994200bus:RegisteredOffice2022-02-012023-01-31059942002023-01-31059942002022-01-3105994200core:LandBuildings2023-01-3105994200core:OtherPropertyPlantEquipment2023-01-3105994200core:LandBuildings2022-01-3105994200core:OtherPropertyPlantEquipment2022-01-3105994200core:CurrentFinancialInstrumentscore:WithinOneYear2023-01-3105994200core:CurrentFinancialInstrumentscore:WithinOneYear2022-01-3105994200core:CurrentFinancialInstruments2023-01-3105994200core:CurrentFinancialInstruments2022-01-3105994200core:ShareCapital2023-01-3105994200core:ShareCapital2022-01-3105994200core:RetainedEarningsAccumulatedLosses2023-01-3105994200core:RetainedEarningsAccumulatedLosses2022-01-3105994200core:LeaseholdImprovements2022-02-012023-01-3105994200core:PlantMachinery2022-02-012023-01-31059942002021-02-012022-01-3105994200core:LandBuildings2022-01-3105994200core:OtherPropertyPlantEquipment2022-01-31059942002022-01-3105994200core:LandBuildings2022-02-012023-01-3105994200core:OtherPropertyPlantEquipment2022-02-012023-01-3105994200core:WithinOneYear2023-01-3105994200core:WithinOneYear2022-01-3105994200bus:PrivateLimitedCompanyLtd2022-02-012023-01-3105994200bus:SmallCompaniesRegimeForAccounts2022-02-012023-01-3105994200bus:FRS1022022-02-012023-01-3105994200bus:Audited2022-02-012023-01-3105994200bus:FullAccounts2022-02-012023-01-31xbrli:purexbrli:sharesiso4217:GBP